Old Web
English
Sign In
Acemap
>
Paper
>
International Differences in the Use of Mepolizumab to Treat Severe Asthma - Impact of Reimbursement Policies
International Differences in the Use of Mepolizumab to Treat Severe Asthma - Impact of Reimbursement Policies
2021
Rekha Chaudhuri
C. Caruso
Geoffrey Chupp
T Fera
T. Koehler
F. Schleich
A. Valero
Shibing Yang
Peter H. Howarth
R. W. Jakes
Aoife C. Maxwell
R G Price
R. Alfonso-Cristancho
Keywords:
Intensive care medicine
Mepolizumab
severe asthma
Reimbursement
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]